Palisade Therapeutics

Palisade Therapeutics Overview

  • Status
  • Private
  • Latest Deal Type
  • Accelerator/​Inc
  • Latest Deal Amount
  • $100K
Latest Deal Amount
  • Investors
  • 2

Palisade Therapeutics General Information


Provider of therapeutics based products intended to treat progressive neurological diseases. The company's therapeutics based products treat with a two-fold, personalized, disease-modifying approach to slow the symptoms and progression of disease in the target population, enabling patients prevent and reverse neurological diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • Li Ka Shing Center
  • 2535 Oxford Street
  • Berkeley, CA 94720
  • United States
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Palisade Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Accelerator/Incubator $100K 000 Completed Startup
1. Accelerator/Incubator 21-Jul-2017 Completed Startup

Palisade Therapeutics Executive Team (2)

Name Title Board Seat Contact Info
Aaron Friedman Ph.D Co-Founder
Vlad Senatorov Ph.D Co-Founder

Palisade Therapeutics Investors (2)

To view Palisade Therapeutics‘s full investor history, request access »
Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
California Institute for Quantitative Biosciences Accelerator/Incubator 000 0000 000000 0
Berkeley SkyDeck Accelerator/Incubator Minority 000 0000 000000 0

Ready to get started?

Request a free trial